Hot Movers: Tesla Motors Inc (NASDAQ:TSLA), VIVUS (NASDAQ:VVUS), Teva Pharmaceutical Industries (NYSE:TEVA), Sony (NYSE:SNE), Advanced Micro Devices (NYSE:AMD)

Tesla Motors Inc (NASDAQ:TSLA) hasn’t changed the look of its Model S sedan since the sumptuous electric car first hit the market in 2012. Tesla Motors Inc (NASDAQ:TSLA) stock performance was -0.08% in last session and finished the day at $229.25. Traded volume was 5.17million shares in the last session and the average volume of the stock remained 6.63million shares. The beta of the stock remained … Continue reading Hot Movers: Tesla Motors Inc (NASDAQ:TSLA), VIVUS (NASDAQ:VVUS), Teva Pharmaceutical Industries (NYSE:TEVA), Sony (NYSE:SNE), Advanced Micro Devices (NYSE:AMD)

Colin Pettis07/0707/07

Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Just a month ago, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) snapped up portfolio company, San Mateo, CA-based Labrys Biologics, for $200 million up front and another $625 million in milestones. That deal came less than two years after Labrys was formed, and venBio partner and co-founder Corey Goodman told Xconomy at the time that venBio had contributed $8.5 million of Labrys’ $31 million Series A round plus an … Continue reading Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Jason Knox07/0307/03

Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Drugmaker Vivus Inc. (NASDAQ:VVUS) said Thursday it has filed a lawsuit against Actavis PLC and its affiliates in a New Jersey federal court over its bid with the U.S. Food and Drug Administration to sell a generic version of company’ prescription weight-loss drug Qsymia. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -0.19% in last session and finished the day at $5.17. Traded volume was 1.03million shares … Continue reading Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Mark DeFrance06/1806/18

Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announced that the U.S. Court of Appeals for the Federal Circuit today upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb’s entecavir compound claim of U.S. Patent No. 5,206,244 invalid. Teva’s ANDA for entecavir has received tentative approval from the U.S. Food and Drug Administration (FDA). Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) … Continue reading Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)

Kevin Long06/1606/16

News Buzz: Teva Pharmaceutical Industries (NYSE:TEVA), World Acceptance (NASDAQ:WRLD), AngioDynamics (NASDAQ:ANGO), The Boeing Company (NYSE:BA)

Pfizer and GlaxoSmithKline are among pharmaceutical companies whose shares advanced after announcing $115 billion of acquisition plans since the end of March. “It’s been like a game of Pac-Man,” said Timothy Chiang, an analyst at CRT Capital Group. Mylan has attempted to negotiate a takeover of Meda, while Chiang said Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has everyone wondering whether it’s going to seek a … Continue reading News Buzz: Teva Pharmaceutical Industries (NYSE:TEVA), World Acceptance (NASDAQ:WRLD), AngioDynamics (NASDAQ:ANGO), The Boeing Company (NYSE:BA)

Kevin Long04/3004/30

Drug Stocks In News: Teva Pharmaceutical Industries (NYSE:TEVA), Allergan (NYSE:AGN), Dynavax Technologies Corporation (NASDAQ:DVAX), ISIS Pharmaceuticals (NASDAQ:ISIS)

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announces the launch of the generic equivalent to Lunesta(R) (Eszopiclone Tablets, CIV), 1, 2 and 3 mg, in the United States. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -0.68% in last session and finished the day at $49.61. Traded volume was 2,806.00million shares in the last session and the average volume of the stock remained 7.21million shares. … Continue reading Drug Stocks In News: Teva Pharmaceutical Industries (NYSE:TEVA), Allergan (NYSE:AGN), Dynavax Technologies Corporation (NASDAQ:DVAX), ISIS Pharmaceuticals (NASDAQ:ISIS)

Kevin Long04/1604/16